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Abstract
This chapter shall provide a brief introduction to the prostheses and their 
development in the current advance technological era. The prosthesis design, 
control, and architecture completely changed with the change in the amputation 
level. The transradial amputee stump design, electronics, battery, and circuit place-
ment change significantly with the change of the residual arm of the amputee. This 
leads to designing the prostheses with the focus of the amputation level and ease of 
customization. Recent development in the 3D printing and open source prosthetic 
design leads the user to choose, modify, and print the prostheses with the required 
sets of functionalities. In this chapter, a brief introduction of the prostheses has 
been given, starting with the types of prostheses according to the level of amputa-
tion and functionality. Then, the state-of-the-art prostheses available commercially 
and under research will be introduced. Afterward, the 3D printed prostheses are 
discussed. This chapter will end with the comparison of the medical advancement 
over the average life of people in general and comparison of the same for countries 
with low and high per capita income.
Keywords: prostheses, upper limb, lower limb, amputation, myoelectric,  
3D printing, state-of-the-art, per capita income
1. Introduction
According to the estimation of the World Health Organization (WHO), 650 million 
individuals suffer from a disability worldwide. About 80% out of 650 million individu-
als reside in developing countries [1]. Among 650 million, approximately 3 million 
suffer from the upper limb amputation and 2.4 million of which live in the developing 
countries [2]. According to the study conducted in 2016, the population of upper limb 
amputation is suffering from 16% transhumeral, 12% transradial, 2% forequarter, 
3% shoulder disarticulation, 1% elbow disarticulation, 2% wrist disarticulation, 61% 
transcarpal, and 3% bilateral limb loss [3]. The rehabilitation services to overcome the 
disability by using prostheses are so uncommon and expensive that only 3% of the 
amputees in the developing countries have access to them [1].
The prostheses are the artificial devices that improve the quality of life of a 
disabled person by replacing the missing or lost limb due to congenital disease or 
trauma or injury [4]. The prostheses may replace the lost or missing limb in terms of 
appearance, functionality, or both. The prostheses may be classified by the level of 
amputation and by their functionality (as shown in Figure 1) [3, 5–7].
This section will begin with the brief introduction of the types of prostheses 
due to amputation and functionality. Then, the commercially available prostheses 
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are discussed, followed by the state-of-the-art prostheses under development. At 
the end of this section, 3D printed prostheses are discussed. Finally, the section is 
concluded with a tabular comparison of all these prostheses highlighting the afford-
ability of the prostheses.
2. Level of amputation
The prosthesis design may change with the change in the amputation level. 
For example, if a person lost the little finger of the right hand, he/she would only 
need an esthetic prosthesis. However, if the level of amputation is wrist, then the 
prosthesis required must have the functionality of all fingers and thumb to grip or 
hold an object. In this section, the level of amputation for upper and lower limbs is 
discussed.
2.1 Upper limb prostheses
The upper limb prosthesis design and functionality varies with the level of 
amputation. There are five main amputation levels for upper limb [3], as shown in 
Figure 2, and each of them is briefly discussed below.
Figure 1. 
Classification of prostheses.
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2.1.1 Wrist disarticulation
In wrist disarticulation, the limb is amputated at the level of the wrist without 
affecting the bones and muscles of the forearm. The amputee is able to perform all 
the movements of the arm and forearm. Also, the amputee can contract the residual 
muscles responsible for wrist and finger movements.
2.1.2 Transradial (below elbow)
In transradial amputation, the amputee loses limb anywhere between wrist and 
elbow. Since the amputee has a portion of forearm, he/she can perform the forearm 
rotation and also contract the residual muscles responsible for most of the wrist and 
finger movements.
2.1.3 Transhumeral (above elbow)
In transhumeral amputation, the amputation is between shoulder and elbow. 
In this type of amputation, the amputee loses all the functionality and muscles of 
forearm, wrist, and hand. The prosthesis used to assist this amputation must have 
the elbow, wrist, and hand function in order to enable the amputee to perform 
activities of daily living (ADL).
2.1.4 Shoulder disarticulation
In shoulder disarticulation, the amputee loses the complete arm with muscles 
and bones. For this type of amputation, the prosthesis required must have the 
functionality of complete arm.
2.1.5 Forequarter
In forequarter amputation, the amputee also loses the shoulder blade and 
collarbone. For this type of amputation, the prosthesis design must have shoulder 
movements too.
Figure 2. 
Level of amputation for upper limb.
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2.2 Lower limb prostheses
Similar to the upper limb, lower limb prosthesis design changes with the change 
in the level of amputation. There are five major levels of amputation at lower limb 
[8], as shown in Figure 3, discussed briefly in this section.
2.2.1 Foot amputation
The foot amputation may occur below the ankle at any part of the foot. In this 
type of amputation, the amputee only needs a robust esthetic prosthesis to help in 
walking.
2.2.2 Transtibial (below knee)
In transtibial amputation, the amputee loses limb between the ankle and knee. 
Most of the time, the residual muscle and bones may be used to drive the prosthesis 
being used to increase the quality of amputee.
2.2.3 Knee disarticulation
In knee disarticulation, the amputation occurs at the knee joint. In this type 
of amputation, the amputee loses muscles and bones below knee; however, the 
muscles responsible for the movements of the leg are intact.
2.2.4 Transfemoral (above knee)
Transfemoral amputation occurs between knee and hip. In this type of amputa-
tion, the amputee loses most of the leg muscles and bone. The prosthesis designed 
for this amputation must include the movements of the knee and ankle.
Figure 3. 
Level of amputation for lower limb.
5Impact of Medical Advancement: Prostheses
DOI: http://dx.doi.org/10.5772/intechopen.86602
2.2.5 Hip disarticulation
In hip disarticulation, the complete leg has been amputated. The amputee may 
not be able to perform hip movements and may need a fully functional biomimetic 
leg prosthesis to recover from his/her disability.
3. Esthetic prostheses
Esthetic prostheses aid the disabled person by masking the attention of the 
public, so that the person may roam around in public without notice. This type 
of prostheses increases the quality of the subject’s personal life by giving them 
confidence, which is essential for a person to perform the activities of daily 
living (ADL).
These types of prostheses are passive and have no active component. The 
main consideration in the design of the cosmetic prostheses is to match  
the exact skin tone texture, nails, and size of the subject. Figure 4(a) shows 
the finger amputation with a cosmetic prosthesis; after wearing the cosmetic 
prosthesis, it is quite difficult to notice the amputation of the subject as shown 
in Figure 4(b) [9].
Figure 4. 
(a) Amputated finger is shown with the esthetic prosthesis before putting it on and (b) after putting on the 
esthetic prosthesis.
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4. Powered prostheses
The powered prostheses are further divided into the following:
1. Body-powered prostheses
2. Electrically powered prostheses
4.1 Body-powered prostheses
The body-powered prostheses aid the disable person in achieving the functional-
ity lost due to the loss of the limb. The body-powered prostheses also increase the 
quality of the subject’s life by allowing them to perform the activities of daily living 
(ADL) without the assistance of another human being.
These types of prostheses consist of a tendon or a cable that is attached with the 
person’s body and by pulling that cable, the body-powered prosthesis performs the 
desired operation [10]. A typical body-powered upper limb prosthesis consists of 
socket, wrist, control cable, harness, and terminal device as shown in Figure 5 [11]. 
The socket is worn on the residual limb, while the harness is worn on the opposite 
shoulder. To open or close the terminal device, the subject moves his/her shoulder, 
which results in the movement of harness, which in turn pulls the control cable. 
Most of the terminal devices in the body-powered prostheses are metal hooks due to 
the fact that it can withstand high loading and easy to control with a single cable-
spring mechanism [12].
4.2 Electrically powered prostheses
Unlike the body-powered prostheses, electrically powered prostheses have 
actuators to perform the opening and closing of the terminal device. The electrically 
Figure 5. 
A typical body-powered upper limb prosthesis.
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powered prostheses are more delicate and versatile that enhance or mimic the 
functionality and appearance of the missing limb of the body.
These types of prostheses usually consist of motors (as an actuator), which is used 
to drive a mechanism to achieve the movements of the terminal device. These motors 
receive control signals from the main controller which, after the analysis of the input 
signal, instructs the motor to achieve desired movements. The electrically powered pros-
theses are further divided into two types on the bases of the sensing or input signals [6].
4.2.1 Mind-controlled prostheses
The mind-controlled prostheses (also called brain-controlled prostheses) 
sense the signal from brain, i.e., electroencephalogram (EEG) [13]. The controller 
extracts the information from the EEG signals after amplification and filtration 
in the form of features. These features are then used by the pretrained classifier to 
classify the desired movement of the prostheses.
4.2.2 Myoelectric prostheses
The myoelectric prostheses use the same mechanism as of mind-controlled pros-
theses. The only difference is the sensing or input signal. In myoelectric prostheses, 
the signal is sensed from the muscle level instead of the brain. These signals are 
named as electromyogram (EMG). The EMG signal is usually sensed at the residual 
muscle of the amputated limb. Therefore, the EMG signals are easy to predict the 
intentions of the user as compared with the EEG signals. On the other hand, EMG 
signals are likely to be dissimilar if the position of the sensor is slightly changed or 
the contraction of the muscle changes [14].
The myoelectric prostheses are the most commonly used prostheses due to 
onsite EMG signal acquisition and relatively simpler control scheme. The state-of-
the-art prostheses [15] for the upper limb will be discussed in this section with the 
open source 3D printing counter prostheses [16].
4.2.2.1 i-Limb by Touch Bionics, UK
Touch Bionics is one of the top companies in producing prostheses for tran-
sradial, wrist disarticulation, and finger amputees. A finger of i-Limb consists of 
four-bar mechanism driven by a DC motor via worm gears. The latest model i-Limb 
Quantum weighs 470 g for the ultrasmall model and 630 g for the large model. The 
four sizes of i-Limb Quantum are shown in Figure 6 [17].
The new i-Limb Quantum has four different modes of control:
1. Trigger muscle control: this is the default control scheme based on a finite state 
machine (FSM). The user contracts his/her muscle to control the prosthesis by 
switching between the states of the FSM.
2. Quick grip app control: the Touch Bionics has introduced a mobile app that can 
communicate with the i-Limb quantum. This app can be used to control the 
prostheses and perform the desired operation without sensing the EMG signals 
from the user’s muscle.
3. Intelligent motion gesture control (i-mo): i-mo makes use of the internal sen-
sors to detect the movement of the prostheses and activate a pre-programmed 
grip on the i-Limb quantum.
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4. Grip chips proximity control: this is the unique programmable feature intro-
duced in i-Limb quantum; whenever the user moves his/her hand near the grip 
chip, the pre-programmed grip will be enabled, allowing the user to quickly 
use that specific grip.
Although the Touch Bionics has developed a state-of-the-art prosthesis, there 
is always a room for improvement. Lack of sensory feedback to control the grip 
limits the performance of the i-Limb. Also, the user must select from the defined 
grips available with the model and preprogram them. Another factor that limits the 
amputee to get the i-Limb prostheses is the high price tag [18].
4.2.2.2 Bebionics by Ottobock, Germany
The Ottobock company has a wide variety of prostheses, including both upper 
limb and lower limb solutions. For consistency, the upper limb hand myoelectric 
prosthesis of Ottobock, i.e., Bebionics, is discussed in this section.
The Bebionic is available in three sizes and weighs between 390 and 600 g, as 
shown in Figure 7 [19]. Each finger of Bebionics is driven by a custom linear actua-
tor through four-bar mechanism. Similar to i-Limb quantum, the Bebionic has an 
FSM-based control scheme to select among the 14 different grip patterns and hand 
positions [20].
The structure of the Bebionic is developed using aerospace industry grade 
aluminum, which gives it a robust structure and is lightweight. The Bebionic suffer 
from the same constraints as of i-Limb due to unavailability of the sensory feed-
back, pre-programmed grip pattern, and high cost.
4.2.2.3 Vincent Hand by Vincent Systems GmbH, Germany
The Vincent Systems GmbH is specialized in producing the myoelectric pros-
thesis hand. Currently, Vincent Evolution 3 has been released with four different 
sizes, i.e., extra small, small, medium, and large. The extra-small size of Vincent 
Evolution 3 is the lightest myoelectric prosthesis hand, which weighs only 386 g 
with the transcarpal wrist [21] (Figure 8).
Each finger of Vincent Evolution 3 comprises of a DC motor that drives the 
four-bar mechanism with the help of worm gear to achieve the flexion-extension of 
the finger. The control scheme of Vincent Hand is a specialized type of FSM, which 
senses two EMG signals and can attain five different grip groups directly from the 
central hand position. Another advantage of the Vincent FSM is that you can jump 
to the central hand position from any grip by a long “open” signal. The “open,” 
“close,” and “trigger” are customizable and the user may choose any other unique 
signal instead of co-contraction [22].
Similar to Bebionics and i-Limb, Vincent Evolution 3 lacks the sensory feedback 
essential to control the grip force. Therefore, Vincent Evolution 3 has prepro-
grammed grips and fingers are coupled with open/close function.
4.2.2.4 Modular prosthetic limb by John Hopkins Applied physics Lab, USA
The modular prosthetic limb (MPL) is the most advanced prosthesis hand 
developed by the John Hopkins Applied Physics Lab, USA, under the umbrella 
of Revolutionizing Prosthetics 2009 (RP 2009) [23]. Unlike the commercially 
available prostheses, MPL contains motor at each joint of the finger. The MPL has 
26 degrees of freedom (DOF) including wrist, elbow, and shoulder movements. 
9Impact of Medical Advancement: Prostheses
DOI: http://dx.doi.org/10.5772/intechopen.86602
The MPL is customizable and can be used for all major upper limb amputation. 
The overall weight of the MPL is 3.5 kg, and the hand with wrist weighs around 
1.32 kg as shown in Figure 9.
The MPL is tested on human subjects who underwent targeted muscle rein-
nervation (TMR) surgery [24]. The TMR surgery is the process of connecting the 
residual motor nerves of lost muscle into the nearest large muscle, so that, the 
intentions of moving the lost muscle can be detected. This technique is quite useful 
for a person who lost a major portion of his/her limb.
The recent development in targeted sensory reinnervation (TSR) technique [25] 
allows the MPL to send the sensory feedback directly to the nerves of the lost limbs. 
This is the major limitation of the commercial prostheses that MPL has overcome 
[26]. In TSR surgery, the residual sensory nerves are connected or reinnervate at the 
nearest large muscle, so that, the sensory feedback of the prostheses can be sensed 
via the electrode. The MPL is the most advanced prostheses, and it is not commer-
cially available yet.
4.2.2.5 Vanderbilt hand by Vanderbilt University, USA
The researchers at the Center for Intelligent Mechatronics Lab at Vanderbilt 
University, USA, have developed a 9 DOF prosthesis hand with 4 degrees of control 
(DOC). The Vanderbilt hand uses four motors with a tendon-spring mechanism 
to achieve essential grips to perform ADL. Instead of using a single motor for each 
finger, Vanderbilt hand uses one motor for the index finger, two motors for thumb, 
and one motor for remaining three fingers (i.e., middle, ring, and pinky). The adult 
human hand-sized Vanderbilt hand weighs around 546 g as shown in Figure 10 [27].
Figure 7. 
The Bebionics V3 by Ottobock, from left to right: small, medium, and large.
Figure 6. 
i-Limb Quantum by Touch Bionics, from left to right: extra small, small, medium, and large.
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The FSM of Vanderbilt hands is shown in Figure 11 [28]. The Vanderbilt hand 
uses two onsite EMG signals for switching between the states of the machine. 
The co-contraction will be used for thumb reposition and opposition states. The 
contraction of the forearm flexor is associated with the upward movement, and 
contraction of the forearm extensor is associated with the downward movement as 
shown in the state diagram of the Vanderbilt hand.
The Vanderbilt hand has a unique mechanism and control scheme, but it lacks the 
functionality and features offered by the MPL. However, the price estimation of the 
Vanderbilt hand is much lower as compared to the MPL.
Figure 9. 
The modular prosthetic limb by John Hopkins Applied Physics Laboratory, USA.
Figure 8. 
Vincent evolution 3 by Vincent Systems GmbH.
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4.2.2.6 Hero Arm by Open Bionics, UK
The Open Bionics has released multiple open source 3D printed prostheses 
including, Dextrus Hand, Ada Hand, Brunel hand, and Hero Arm. The latest and 
most advance among all, i.e., the Hero Arm is shown in Figure 12. The Hero Arm 
is designed for a person with transradial amputation. There are two versions of the 
Hero Arm, one with four-motor-drive mechanism and other with three-motor-
drive mechanism. The only difference is that the index and middle fingers are 
actuated with a single motor in a three-motor version.
The Hero Arm has tendon-flexure-based mechanism for flexion extension of 
the finger. The control scheme of the Hero Arm consists of FSM that utilizes the 
contraction of wrist flexion and extension muscles. The trigger signal for switching 
the grip is open signal, pause, and then holds the open signal for 1 s. Further details 
of the Hero Arm can be found at [29].
The main advantages of the 3D printed prostheses are low cost, easy modifica-
tion, and customization. On the other hand, 3D printed prostheses mostly lack the 
performance and robustness offered by the commercial prostheses [16].
4.2.2.7 Tact Hand by University of Illinois, USA
The Tact Hand is another open source prosthesis hand developed by the 
researchers at the University of Illinois. Each finger of the Tact Hand is driven by a 
DC motor through the string. The string is attached with the underactuated four-
bar mechanism of the finger. As the motor rotates clockwise, it winds up the string 
on the spool, creating tension in the string, which in turn flexes the finger. The 
rubber band attached at the back of the finger assists in the extension of the finger 
when the motor rotates anticlockwise, releasing the tension in the spring as shown 
in Figure 13 [30].
Tact Hand is the cheapest 3D printed prostheses as claimed by the author [30]. 
However, it lacks the esthetic look, robustness, and durability, offered by most of 
the commercial prostheses.
Table 1 summarizes the characteristics of the commercial and 3D printed 
hand prostheses discussed in this section. All the prostheses use an underactuated 
mechanism to reduce the complexity of the hand design. Underactuated mechanism 
not only reduces the requirement of the actuators at each joint, but also simplifies 
the control scheme of the hand, which in turn reduces the weight of the prosthetic 
Figure 10. 
Third-generation Vanderbilt hand by the Center for Intelligent Mechatronics.
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hand. The Hero Arm is the lightest among the studied prostheses with weight as low 
as 280 g. The actuator used by the commercial and 3D printing prostheses is DC 
motor. The most common configuration is to use DC motor with worm gear, lead 
screw or spool, and tendon to translate the motor rotation into the finger flexion 
Figure 12. 
The Hero Arm from Open Bionics.
Figure 11. 
The finite state machine of the Vanderbilt hands.
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extension through the four-bar mechanism. This mechanism is housed inside each 
finger/thumb with the dimension as close as the dimension of a normal healthy 
adult for large size prosthesis and relatively smaller for medium and small versions 
to fit younger subjects.
5. Impact of advancement in prostheses and medical devices
Owing to the technological boom in the twenty-first century, the healthcare 
industry has also advanced considerably. This progress is evident in all subfields of 
the healthcare systems. Surgical procedures have moved on from bone drillings to 
Hand/
developer
Mass 
(g)
Size (L × W × H) 
(mm)
Joints/
DOF
No. of 
actuators
Actuation 
method
Joint 
coupling
Cost 
(USD)
Tact/
University of 
Illinois [30]
350 200 × 98 × 27 11/6 6 DC motor-
tendons
Linkage 
spanning 
MCP to PIP
250*
Ada V1.1/
Open Bionics 
[31]
380 215 × 178 × 58 10/5 5 Linear 
actuator 
tendons
Tendon 
linking to 
MCP to the 
fingertip
1200
Hero Arm/
Open Bionics 
[29]
280–
346
— 10/3–4 3–4 DC motor 
tendons
Tendon 
linking to 
MCP to the 
fingertip
—
i-Limb/
Touch 
Bionics [17]
450–
615
180–182 × 75–80 
× 35–41
11/6 6 DC motor-
worm gear
Tendon 
linking to 
MCP to PIP
40,000
Bebionic V2/
RSL Steeper 
[32]
495–
539
190–200 × 
84–92 × 50
11/6 5 DC motor-
lead screw
Linkage 
spanning 
MCP to PIP
35,000
Vincent 
Hand/
Vincent 
System [21]
— — 11/6 6 DC motor-
worm gear
Linkage 
spanning 
MCP to PIP
—
*Exclusive of motors and circuit cost.
Table 1. 
Characteristic comparison of the prosthesis hand.
Figure 13. 
Tact: an open source hand prosthesis.
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innovations like robotic surgeries, MARVEL (multiangle rear-viewing endoscopic 
tool), and surgical glasses. The field of biomedical imaging has advanced from x-ray 
imaging to molecular imaging. Likewise, rehabilitation engineering has moved 
on from wooden dentures and minimalist crutches to cyborg body prostheses. 
Pharmaceutics has now headed toward immunotherapy, pharmacogenetic testing, 
and RNA therapeutics.
It is now a common notion that such rapid advancement in biomedical innova-
tion and research is the leading cause of improvement in the quality of human life 
and longevity [33]. A number of studies credit this increase in longevity to the 
pharmaceutical innovations, which has appeared to be the most research-intensive 
subfield of the healthcare industry. Lichtenberg has proved time and again that 
pharmaceutical innovations have a profound effect on health and longevity [34–41]. 
By his research, he cemented the notion that drug innovations decrease mortality 
rate, hospitalization rate, and improve the general well-being of the society.
Through similar studies, authors have linked the advancement in biomedi-
cal innovations to increase the longevity and general betterment of health. For 
example, Cutler et al. concluded that the ultimate determinant of health is scientific 
advancement and progress, which in turn is influenced by economic and aca-
demic growth [42]. Another study considering the USA population found that the 
improved health of genial Americans is owing to the advancement in medical tech-
nologies [43]. Fuchs also asserts that the primary cause of increased longevity is the 
fruit of biomedical innovations after the Second World War [44]. Furthermore, the 
National Institutes of Health (NIH) claims that their research has enabled average 
Americans to live 30 years more (in 2012) than they did in 1900 [45]. The variables, 
inspected the most in such studies, are the medical services and procedures preva-
lent in the population and the availability of drugs and healthcare artifacts for the 
people. Lichtenberg studied medical care and behavioral risk factors in increasing 
or decreasing longevity [46].
While the outcome variable that is usually inspected in these studies is longevity, 
defined as “a long duration of individual life” or “the length of life” by Merriam-
Webster Dictionary [47], another important outcome measure is the performance 
of activities of daily living (ADLs) under the influence of medical interventions.
The effects of biomedical innovations other than pharmaceutical innovations 
on health and longevity are comparatively more difficult to gauge as there are 
fewer researches on this topic. As evident from the fact that more than 50% of the 
research on biomedical innovations is provided by pharmaceutical companies, 
other researches take a back seat [48].
In most of the cases, the biomedical technological advancements are not easy 
to gauge. An extensive amount of data is required to measure the availability of 
healthcare facilities, and even more difficult is to quantify the qualitative nature 
of the healthcare facilities. In order to solve this problem, a surrogate measure is 
taken for the biomedical advancement that is the per capita income of the popu-
lation in consideration. The reliability of gross domestic product (GDP) as an 
indicator of biomedical advancement is asserted by the World Health Organization 
(WHO) when it continuously lauds France for its excellent biomedical system, 
with a GDP per capita of USD 46732 in 2019. Furthermore, the Organization for 
Economic Co-operation and Development (OECD), in its official magazine, the 
OECD Observer, reports that a 10% increase in life expectancy makes up an annual 
0.3–0.4% growth in the economy, proving that the relationship is bidirectional 
[49]. On the other hand, the countries with lower GDP have been reported to have 
a life expectancy rate by a study that analyzed the 213 years’ worth of data [50]. 
One obvious reason for this relationship is the fact that people with less economic 
stability tend to avoid getting treatment for “minor” health issues such as malaria, 
15
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flu, and infections. This leads to worsening of the symptoms and eventually casual-
ties that would otherwise have been easily avoided. Also, if there is an endemic in 
the country like Ebola, tourism and foreign visits tend to dry up, setting back the 
economy further.
Taking this into consideration, we attempted to find a relationship between the 
GDP of the countries of the world with the expected life in years for the year 2018. 
The methodology and results are stated in the following sections.
6. Data acquisition
In order to analyze the annual per capita income of the countries, the World 
Economic Outlook database of the International Monetary Fund (IMF) was 
accessed, as provided freely by the Gapminder Foundation [51]. The data from 
183 countries for 10 years (2009–2018) were filtered to match the available data 
of the life expectancy rate of different countries. The estimated lifespans of the 
countries were retrieved from Geobase [52].
7. Regression analysis
For statistical analysis of the data, we performed regression analysis via IBM 
SPSS Statistics. The regression analyses are performed taking GDP as the indepen-
dent variable and life expectancy as the dependent variable. We used the natural 
logarithm to GDP values. The resultant R2 values are plotted in Figure 14.
It is evident from the graph that over the decade, the GDP alone explains 
47–69% of the cross-country variation in life expectancy. This strengthens the 
notion that GDP per capita income is an important contributor in prolonging the 
life of the individuals.
8. Quartile mapping
For the sake of ease, we mapped the GDP per capita income and life expectancy 
for 2018 on the world map, see Figures 15 and 16. The mapping is done by first 
defining four quartiles of each variable. The cutoff points for each quartile are men-
tioned in the captions of these two figures. By keeping the color coding same for 
Figure 14. 
R2 values for cross-sectional regressions by years.
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the quartiles of both the variables, we attempted to make the comparison of both 
variables making it apparent. Quartiles were calculated with the help of the buvilt-
in QUARTILE function of MS excel for each of the two data groups. The mapping 
was performed using the online tool provided by www.mapchart.net.
9. Discussion
In this chapter, we first had an overview of the biomedical innovations of the 
current times. We then hypothesized that these innovations may have a profound 
effect on the life expectancy and general health of the population. For this, we 
revisited the relationship of GDP per capita income to the life expectancy, taking 
GDP as the surrogate measure of the health facilities provided in the country. 
Our analyses included data for the past 10 years (2009–2018) for 183 countries. 
Figure 16. 
Mapping of the world according to the four quartiles of the longevity of the countries. Where quartile 1 is 0 to 
67.25 years, quartile 2 is 67.3 to 74.15 years, quartile 3 is 74.2 to 78.125 years, and quartile 4 is 78.2 to 84.2 years.
Figure 15. 
Mapping of the world according to the four quartiles of the GDP per capita income of the countries. Where 
quartile 1 is 0 to 2297.5 USD, quartile 2 is 2297.6 to 5874 USD, quartile 3 is 5874.1 to 17617.5 USD, and quartile 
4 is 17617.6 to 129,710 USD.
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These analyses targeted one key question: does life expectancy increase with 
increasing income?
Overall, the analysis of the GDP and life expectancy data of the past 10 years 
suggests a considerable correlation between income level and life expectancy. It is 
to be noted that biomedical innovations are more likely to be bought and utilized in 
countries with stronger economies and higher income levels. Hence, the longevity 
of their citizens increases. In contrast, the countries with poorer economies are 
unable to possess the latest biomedical innovation and hence have shorter lifespans 
and worse quality of life of their citizens.
As a future direction, the research and development (R&D) of biomedical tech-
nology should weigh in the factor of affordability and mass production. For this, 
the researches may opt for cheaper and locally available materials while building the 
end product. Also, the outsourcing of R&D and production of these technologies 
will create more employment options in developing countries.
10. Conclusion
The results of our analyses showed that there exists a direct positive relationship 
between per capita income and the expected years of life across countries. These 
results support our hypothesis that growth in the biomedical industry and a resul-
tant growth in the healthcare industry will have a positive impact on the economy. 
This positive impact will improve the longevity of the people.
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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